Titre : | Misuse of "study drugs:" prevalence, consequences, and implications for policy (2006) |
Titre traduit : | (Mésusage de "drogues des études" : prévalence, conséquences et implications politiques) |
Auteurs : | S. SUSSMAN ; M. A. PENTZ ; SPRUIJT-METZ D. ; T. MILLER |
Type de document : | Article : Périodique |
Dans : | Substance Abuse Treatment, Prevention, and Policy (Vol.1, n°15, 2006) |
Article en page(s) : | 7 p. |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés VOIE D'ADMINISTRATION ; JEUNE ADULTE ; PREVALENCE ; ABUS ; STIMULANTS ; MEDICAMENTS ; MILIEU ETUDIANT ; POLITIQUEThésaurus géographique ETATS-UNIS |
Résumé : | Background: Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. Results: Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. Conclusion: Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts. (Author' s abstract) |
Domaine : | Autres substances / Other substances |
Refs biblio. : | 39 |
Affiliation : | Preventive Medicine and Psychology, Institute for Health Promotion and Disease Prevention Research, University of Southern California, Alhambra, CA, USA |
Numéro Toxibase : | 1301961 |
Centre Emetteur : | 13 OFDT |
Lien : | http://www.substanceabusepolicy.com/content/1/1/15/ |
Accueil